Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
X-linked form of Opitz G/BBB syndrome.
Features include always present findings: Telecanthus; and very common findings: Hypertelorism, Difficulty swallowing (dysphagia), and Hypospadias. 40 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Head and neck | 9 | Unilateral cleft lip, Laryngeal cleft, Thin upper lip vermilion |
Brain and nerves | 3 | Mild intellectual disability, Difficulty swallowing (dysphagia), Global developmental delay |
Digestive system | 2 | Gastroesophageal reflux, Difficulty swallowing (dysphagia) |
Heart and blood vessels | 1 | Ventricular septal defect |
Pregnancy and birth | 1 | Congenital posterior urethral valve |
Growth and development | 1 | Growth delay |
MID1-related Opitz G/BBB syndrome (MID1-OS) is characterized by facial anomalies, genitourinary abnormalities, laryngotracheoesophageal defects, and congenital heart defects. Developmental delay and intellectual disability are common. Clinical manifestations are most evident in affected males, although wide clinical variability has been described, even among members of the same family. To date, 90 individuals have been identified with a pathogenic variant in MID1 and are reported together with their clinical synopsis [, , , , , , , , , , , , , , ].
Table 2.
MID1-Related Opitz G/BBB Syndrome: Frequency of Select Features in Males
Feature | % of Males w/Feature
Hypertelorism | ~100%
Hypospadias | 90%
Laryngotracheoesophageal defects | 70%
Cleft lip /or palate | 48%
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
MID1 encodes midline 1 (667 aa). Has E3 ubiquitin ligase activity towards IGBP1, promoting its monoubiquitination, which results in deprotection of the catalytic subunit of protein phosphatase PP2A, and its subsequent degradation by ... Highest expression in Colon Sigmoid (23.2 TPM) and Bladder (13.8 TPM).
X-linked Opitz G/BBB syndrome is caused by mutations in the MID1 gene on chromosome X.
The MID1 protein participates in Btn-ACACB:2Mn2+ polymer carboxylates Ac-CoA to form Mal-CoA, Btn-ACACA:2Mn2+ polymer carboxylates Ac-CoA to form Mal-CoA, and Formation of Malonyl-CoA from Acetyl-CoA (liver) pathways.
MID1 is classified as a druggable target (B30 2 Spry Domain, Druggable Genome, and Enzyme categories) with score 0.0.
In general, no genotype-phenotype correlations have been observed. Pathogenic missense, nonsense, splice site, and frameshift variants, insertions, and deletions all result in highly variable phenotypes even within the same family . Two possible exceptions are:
An association between truncating variants and the presence of anatomic brain abnormalities, in particular cerebellar defects ;
Possible correlation of a mild phenotype with pathogenic variants in the fibronectin type III domain of the protein .
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
Usually, the presence of an MID1 pathogenic variant is associated with clinical findings of MID1-OS.
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
For the purposes of this GeneReview, the terms "male" and "female" are narrowly defined as the individual's biological sex at birth as it determines clinical care .
MID1-related Opitz G/BBB syndrome (MID1-OS) should be suspected in a male with the following clinical and imaging findings and family history.
Clinical findings
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
Table 3. Genes of Interest in the Differential Diagnosis of MID1-Related Opitz G/BBB Syndrome
Gene/ Genetic Mechanism | Disorder | MOI | Features of This Disorder |
|---|---|---|---|
Overlapping w/MID1-OS | Distinguishing from MID1-OS 22q11.2 deletion | 22q11.2 deletion syndrome1 | AD |
CASK | CASK-related FG syndrome/ XL ID ± nystagmus2 (See CASK Disorders.) | XL |
Genetic testing for MID1 is available. Testing is considered confirmatory for diagnosis.
No approved treatments are currently available for X-linked Opitz G/BBB syndrome. The disease remains an area of unmet medical need.
Evaluations Following Initial Diagnosis To establish the extent of disease and needs in an individual diagnosed with MID1-related Opitz G/BBB syndrome (MID1-OS), the evaluations summarized in by a multidisciplinary team (including craniofacial surgeon, ophthalmologist, pediatrician, pediatric urologist, cardiologist, pulmonologist, speech-language pathologist, and clinical geneticist) are recommended if they have not already been performed. Table 4. MID1-Related Opitz G/BBB Syndrome: Recommended Evaluations Following Initial Diagnosis
System/Concern | Evaluation | Comment |
|---|---|---|
General | Past medical history physical exam w/attention to palate, heart, genitourinary system, lower respiratory system | Cleft lip /or palate |
Urogenital abnormalities | Assessment of hypospadias by urologist, incl ultrasound exam to evaluate for urinary tract dysfunction in males w/severe hypospadias | — |
LTE defects | Laryngoscopy chest x-ray in persons who have choking w/feeding, recurrent pneumonia, /or aspiration | — |
Developmental delay | Developmental eval | — |
Congenital heart disease | Echocardiogram | — |
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
Search ClinicalTrials.gov in the US and EU Clinical Trials Register in Europe for information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
View trials for X-linked Opitz G/BBB syndrome
To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. MID1-Related Opitz G/BBB Syndrome: Recommended Surveillance
System/Concern | Evaluation | Frequency |
|---|---|---|
Cleft lip/palate | Craniofacial team follow up for those w/cleft lip/palate | Per craniofacial specialists |
Hearing | Audiology eval | Annually or as needed |
Urogenital abnormalities | Urology follow up for those w/significant hypospadias /or other urinary tract abnormalities | Per urologist /or nephrologist |
LTE defects | Gastroenterology, pulmonology, /or surgical team follow up for those w/LTE defects | As needed |
Development | Monitoring of developmental progress educational needs | At each visit |
Congenital heart disease | Cardiac follow up for those w/cardiac defects | Per cardiologist |
Anal abnormalities | Gastroenterology /or surgical follow up for those w/anal defects | Per gastroenterologist or surgical team |
Ophthalmologic manifestations | Ophthalmology assessment | Per ophthalmologist |
Family/Community | Assess family need for social work support (e.g., palliative/respite care, home nursing, other local resources), care coordination, or follow-up genetic counseling if new questions arise (e.g., family planning). | At each visit LTE = laryngotracheoesophageal |
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
Phenotype severity distribution: 1 always present feature, 3 very common features, 4 common features.
No clinical trials have been registered for X-linked Opitz G/BBB syndrome.
7 publications have been identified in PubMed for X-linked Opitz G/BBB syndrome. Research spans Basic Science / Preclinical (57%), Case Report / Case Series (29%), and Review / Meta-Analysis (14%).
Wu Q (2026). [PMID: 41842826](https://pubmed.ncbi.nlm.nih.gov/41842826/). *The Journal of craniofacial surgery*. [Case Report / Case Series]
Bertin M (2026). [PMID: 41535291](https://pubmed.ncbi.nlm.nih.gov/41535291/). *Nature communications*. [Basic Science / Preclinical]
Demir M (2026). [PMID: 41592542](https://pubmed.ncbi.nlm.nih.gov/41592542/). *Allergy, asthma & immunology research*. [Basic Science / Preclinical]
Yan Y (2025). [PMID: 40350402](https://pubmed.ncbi.nlm.nih.gov/40350402/). *Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics*. [Case Report / Case Series]
Szczawińska-Popłonyk A (2025). [PMID: 41111099](https://pubmed.ncbi.nlm.nih.gov/41111099/). *Immunologic research*. [Review / Meta-Analysis]
Mascaro M (2024). [PMID: 38508475](https://pubmed.ncbi.nlm.nih.gov/38508475/). *Biochimica et biophysica acta. Molecular basis of disease*. [Basic Science / Preclinical]
Frank S (2024). [PMID: 38238086](https://pubmed.ncbi.nlm.nih.gov/38238086/). *Life science alliance*. [Basic Science / Preclinical]
Data assembled from 8 of 12 sources · Last updated Sep 19, 2026, 4:31 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Common questions about X-linked Opitz G/BBB syndrome
Facial dysmorphism; Cryptorchidism; DD; Feeding problems
EFNB1 | Craniofrontonasal dysplasia (OMIM 304110) | XL | Facial dysmorphism; Cleft lip/palate; Hypospadias; DD; Hypoplasia or agenesis of corpus callosum |
MED12 | MED12-related FG syndrome (See MED12-Related Disorders.) | XL | Facial dysmorphism; Congenital heart defects; Cryptorchidism; DD/ID |
SPECC1L | SPECC1L syndrome3 (also referred to as AD Opitz G/BBB syndrome Teebi hypertelorism syndrome 1 [OMIM 145420]) | AD | Facial dysmorphism; Cleft lip/palate; Congenital heart defects; DD/ID |
Mowat-Wilson syndrome | AD | Facial dysmorphism; Cardiovascular defects; Hypospadias; DD; Hypoplasia or agenesis of corpus callosum | Ocular gastrointestinal abnormalities; Short stature; Pectus excavatum AD = autosomal dominant; DD = developmental delay; ID = intellectual disability; MOI = mode of inheritance; XL = X-linked It is now recognized that 22q11. |
Source: GeneReviews — "MID1-Related Opitz G/BBB Syndrome"
Anal abnormalities |
Assessment of anal position patency |
— |
Ophthalmologic manifestations | Complete ophthalmology eval incl assessment of visual acuity, refractive error, ocular alignment for possible strabismus | — |
Genetic counseling | By genetics professionals1 | To inform affected persons their families re nature, MOI, implications of MID1-OS to facilitate medical personal decision making Family support |
resources | By clinicians, wider care team, family support organizations | Assessment of family social structure to determine need for:; Community or such as Parent to Parent; Social work involvement for parental support; Home nursing referral LTE = laryngotracheoesophageal; MID1-OS = MID1-related Opitz G/BBB syndrome; MOI = mode of inheritance 1. |
MID1-Related Opitz G/BBB Syndrome: Treatment of Manifestations Manifestation/Concern | Treatment | Considerations/Other Cleft lip /or palate |
Urogenital abnormalities | Surgical intervention as needed for hypospadias | LTE defects |
Development | Neuropsychological educational support | Many males w/MID1-OS require special educational programs. |
Congenital heart disease | Surgical repair as needed for congenital heart defects | — |
Anal abnormalities | Surgical intervention for imperforate anus | — |
Ophthalmologic manifestations | Surgical treatment as needed by an ophthalmologist /or refractive lenses | LTE = laryngotracheoesophageal; PE = pressure equalization To monitor existing manifestations, the individual's response to supportive care, and the emergence of new manifestations, the evaluations summarized in are recommended. Table 6. |